In Vivo Evidence for Antioxidant Potential of Estrogen in Microvessels of Female Spontaneously Hypertensive Rats
- 1 February 2002
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 39 (2), 405-411
- https://doi.org/10.1161/hy0202.102993
Abstract
In studies conducted in vitro, it has been demonstrated that estrogen has an antioxidant potential that may contribute to its protective effects on the cardiovascular system. However, the antioxidant effect of estrogen in vivo has not been demonstrated. To address this issue, in this study the effects of estrogen on oxidative stress were evaluated in microvessels studied in vivo. Oxidative stress was evaluated by using intravital microscopy in mesenteric arterioles from female spontaneously hypertensive rats (SHR) in physiological estrous (OE), ovariectomized (OVX), OVX treated with estradiol (E 2 ), or estradiol + progesterone (E/P). The mesenteries were superfused with hydroethidine, a reduced and nonfluorescent precursor of ethidium bromide (EB). In the presence of reactive oxygen species, hydroethidine is transformed intracellularly in EB, which binds to DNA and can be detected by its red fluorescence. The percentage of EB-positive nuclei along the arteriolar wall in OVX (28.4±4.3) was significantly increased compared with OE (14.2±3.9; P 2 (15.7±2.2) and E/P (14.8±0.8). Treatment with the superoxide dismutase mimetic MnTMPyP attenuated by 75% the oxidation of hydroethidine in both OE and OVX. Conversely, mannitol, that decomposes hydroxyl radical, and L-NAME, a nitric oxide synthase inhibitor, had no significant effects on hydroethidine oxidation. No differences on hydrogen peroxide plasma concentration were observed among the groups, suggesting that superoxide anion is the most likely oxyradical involved in the increased oxidative stress observed in OVX. The treatment of mesenteries with diphenyleneiodonium (DPI), an nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase inhibitor, but not with oxypurinol, a xanthine-oxidase inhibitor, produced a significant reduction of oxyradical generation in OVX microvessels and a slight decrease in those from OE. Chronic treatment of female SHR with losartan caused similar decreases in oxyradicals in both OE and OVX, whereas diclofenac and verapamil had no effects. Together these data suggest that estrogen reduces superoxide anion bioavailability in vivo. The antioxidant effect of estrogen, which can contribute to a less pronounced endothelial dysfunction in female SHR, may be dependent on a direct modulatory action of estrogen on NADPH activity.Keywords
This publication has 19 references indexed in Scilit:
- In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytesSteroids, 2000
- Synergistic effect of angiotensin-(1–7) on bradykinin arteriolar dilation in vivoPeptides, 1999
- The need for wider utilization of thrombolytic therapyClinical Cardiology, 1997
- Superoxide anion formation from lucigenin: an electron spin resonance spin‐trapping studyFEBS Letters, 1997
- Estrogen Increases Endothelial Nitric Oxide by a Receptor Mediated SystemBiochemical and Biophysical Research Communications, 1995
- In vitro modulation of antioxidant enzyme levels in normal hamster kidney and estrogen-induced hamster kidney tumorFree Radical Biology & Medicine, 1994
- Free Radicals as Mediators of Tissue Injury and DiseaseCritical Reviews in Toxicology, 1993
- The measurement of free radical reactions in humansFEBS Letters, 1987
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationAmerican Heart Journal, 1986
- The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activityThe Journal of Steroid Biochemistry and Molecular Biology, 1981